Study of ImmunoPet Imaging of PD-L1 in Tumors Using 89Zr-DFO-REGN3504 in Adult Participants With Advanced PD-L1 Positive Malignancies
Clinical trial NCT03746704 · TERMINATED
Trial details
- NCT number
- NCT03746704
- Sponsor
- Regeneron Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-04
- Primary completion
- 2021-07-08
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.